Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.13 (
protein kinase C
)
49,245
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The activation of Na-H exchange in adult rat heart myocytes was characterized in response to a phorbol ester (phorbol 12-myristate 13-acetate) and an alpha 1-adrenergic agonist [6-fluoronorepinephrine (6F-NE)]. Transport activation was assessed by determining the initial rate with which intracellular pH (pHi) was returned from an acid pulse and by following changes in steady-state pHi; pHi was determined by a pH-sensitive fluorescent dye. Both agonists shifted the intracellular pH dependence of Na-H exchange by 0.10-0.15 pH units in the alkaline direction. This shift was prevented by the presence of sphingosine and 1-(5-isoquinolinylsulfonyl)-
2-methylpiperazine
(H-7), inhibitors of
protein kinase C
. The agonists also alkalinized pHi at steady state. The alkalinization by 6F-NE was blocked by prazosin and H-7. This indicates that the adrenergic stimulation of cardiac Na-H exchange is mediated by an alpha 1-adrenergic mechanism and very likely involves the activation of
protein kinase C
.
...
PMID:Alpha 1-adrenergic stimulation of Na-H exchange in cardiac myocytes. 135 93
We examined the effects of mammalian lignans, enterolactone, prestegane B and 2,3-dibenzylbutane-1,4-diol (DBB) on superoxide production and luminol-dependent chemiluminescence (LCL) response in human polymorphonuclear leucocytes (PMNs). The three lignans had no direct effect on the responses of human PMNs. DBB and prestegane B enhanced the superoxide production and LCL response induced by formylmethionyl-leucyl-phenylalanine (fMLP), but enterolactone inhibited fMLP-induced effects. The effects of DBB were stronger than those of prestegane B and the effects of DBB were inhibited by bromophenacyl bromide, mepacrine, N-(6-aminophenyl)-5-chloro-1-naphthalene, sulphonamide and trifluoroperazine, but not by gossypol, nordihydroguaretic acid, indomethacin, staurosporine, 1-(5-isoquinolinesulphonyl)-
2-methylpiperazine
dihydrochloride or (R,S)-2-methoxy-3-(octadecyl-carbamoyloxy)-propyl-2-(2-thiazoli o)-ethylphosphate. These results suggest that DBB primes the responses of human PMNs, and the priming effect is caused by the activation of phospholipase A2--and Ca(2+)-calmodulin-pathways, but not by the activation of lipoxygenase, cyclo-oxygenase and
protein kinase C
or by the release of platelet activating factor.
...
PMID:Effect of mammalian lignans on fMLP-induced oxidative bursts in human polymorphonuclear leucocytes. 136 May 14
The effects of platelet-derived growth factor (PDGF) on phospholipase D (PLD) activity and deoxyribonucleic acid (DNA) synthesis in rat C6 glioma cells have been investigated. Pretreatment of serum-starved C6 cells with PDGF results in enhanced choline production and the phosphatidylethanol (PEt) formation in the presence of ethanol, indicating the activation of PLD acting on phosphatidylcholine (PC). The dose-response curve for choline generation and DNA synthesis were comparable. In addition, the effects of PDGF on both PEt formation and [3H]thymidine incorporation into acid-precipitable material was blocked by the potent
protein kinase C
(
PKC
) inhibitor 1-(5-isoquinolinesulphonyl)-
2-methylpiperazine
(H-7) but not by N-(2-guanidinoethyl)-5-isoquinolinesulphonamide (HA1004), a relatively weak inhibitor of
PKC
, suggesting that PDGF plays an important role as a positive regulator of glioma cell growth via a PLD-mediated mitogenic signal transduction cascades, which depends largely on the activation of
PKC
.
...
PMID:Activation of phospholipase D by platelet-derived growth factor (PDGF) in rat C6 glioma cells: possible role in mitogenic signal transduction. 136 54
The shape changes and membrane ruffling that accompany neutrophil activation are dependent on the assembly and reorganization of the actin cytoskeleton, the molecular basis of which remains to be clarified. A role of
protein kinase C
(
PKC
) has been postulated because neutrophil activation, with the attendant shape and membrane ruffling changes, can be initiated by phorbol esters, known activators of
PKC
. It has become apparent, however, that multiple isoforms of
PKC
with differing substrate specificities exist. To reassess the role of
PKC
in cytoskeletal reorganization, we compared the effects of diacylglycerol analogs and of
PKC
antagonists on kinase activity and on actin assembly in human neutrophils. Ruffling of the plasma membrane was assessed by scanning EM, and spatial redistribution of filamentous (F)-actin was assessed by scanning confocal microscopy. Staining with NBD-phallacidin and incorporation of actin into the Triton X-100-insoluble ("cytoskeletal") fraction were used to quantify the formation of (F)-actin. [32P]ATP was used to detect protein phosphorylation in electroporated cells. Exposure of neutrophils to 4 beta-PMA (an activator of
PKC
) induced protein phosphorylation, membrane ruffling, and assembly and reorganization of the actin cytoskeleton, whereas the 4a-isomer, which is inactive towards
PKC
, failed to produce any of these changes. Moreover, 1,2-dioctanoylglycerol, mezerein, and 3-(N-acetylamino)-5-(N-decyl-N-methylamino)-benzyl alcohol, which are nonphorbol activators of
PKC
, also promoted actin assembly. Although these effects were consistent with a role of
PKC
, the following observations suggested that stimulation of conventional isoforms of the kinase were not directly responsible for actin assembly: (a) Okadaic acid, an inhibitor of phosphatases 1 and 2A, potentiated PMA-induced protein phosphorylation, but not actin assembly; and (b) PMA-induced actin assembly and membrane ruffling were not prevented by the conventional
PKC
inhibitors 1-(5-isoquinolinesulfonyl)-
2-methylpiperazine
, staurosporine, calphostin C, or sphingosine at concentrations that precluded PMA-induced protein phosphorylation and superoxide production. On the other hand, PMA-induced actin assembly was inhibited by long-chain fatty acid coenzyme A esters, known inhibitors of nuclear
PKC
(nPKC). We conclude that PMA-induced actin assembly is unlikely to be mediated by the conventional isoforms of
PKC
, but may be mediated by novel isoforms of the kinase such as nPKC.
...
PMID:Phorbol ester-induced actin assembly in neutrophils: role of protein kinase C. 137 Apr 99
Endothelin (ET), a potent stimulator of atrial natriuretic factor (ANF) secretion in atrial myocyte cultures, has been hypothesized to act via the stimulation of
protein kinase C
(
PKC
). This study was carried out in order to determine if ET activates
PKC
in atrial cultures and whether this activation fully accounts for the effects of ET on ANF secretion. By monitoring the phosphorylation of p80 upon exposure to phorbol ester or ET, it was shown that ET activated
PKC
in atrial cultures, but to a lesser extent than phorbol ester. In contrast, ET stimulated ANF secretion to a level five times greater than phorbol ester, indicating that
PKC
activation alone does not fully account for the effects of ET on ANF secretion. Down-regulation of
PKC
or exposure to the
PKC
inhibitor 1-(5-isoquinolinesulfonyl)-
2-methylpiperazine
dihydrochloride (H7) resulted in a 50% decrease in ET-stimulated ANF secretion. Interestingly, increasing calcium influx with BAY K 8644 stimulated ANF secretion but did not effect the phosphorylation of p80, indicating a
PKC
-independent pathway of ANF secretion. Similarly, a component of ET-stimulated secretion that required calcium influx was independent of
PKC
activation but was sensitive to the Ca2+/calmodulin kinase (CaMK) inhibitor KN-62. Complete inhibition of ET-mediated ANF secretion was obtained only in the presence of both H7 and KN-62. These results demonstrate that ET activates
PKC
in atrial myocyte cultures and that the full effects of ET on ANF secretion require both
PKC
and Ca2+/calmodulin kinase activities.
...
PMID:Protein kinase C and calmodulin kinase are required for endothelin-stimulated atrial natriuretic factor secretion from primary atrial myocytes. 137 96
Transforming growth factor-beta 1 (TGF-beta 1) regulates the expression of the carcinoembryonic antigen (CEA) gene family in the human colon carcinoma cell line Moser. The mechanisms through which it acts, however, are unknown. In this communication, several lines of evidence are presented to show that the induction of CEA expression and secretion (collectively called CEA responses) by TGF-beta 1 is associated with
protein kinase C
(
PKC
) pathway of signal transduction. Treatment of intact cells with the
PKC
-specific inhibitor calphostin C down-modulated cellular
PKC
phosphotransferase activity and blocked the induction of the CEA responses by TGF-beta 1. Depletion of
PKC
by treatment of intact cells with phorbol ester also blocked the action of TGF-beta 1. The induction of the CEA responses by TGF-beta 1 was also blocked by the protein kinase inhibitor 1-(isoquinolinesulfonyl)-
2-methylpiperazine
dihydrochloride (H-7), which also inhibited cellular
PKC
activity. However, TGF-beta 1 did induce the CEA responses in intact cells treated with the calmodulin antagonist N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide hydrochloride (W-7), the calmodulin-dependent phosphodiesterase inhibitor calmidazolium, the diacylglycerol kinase inhibitor R59 022, and the G-protein inhibitors cholera toxin and pertussis toxin. Treatment of intact cells with TGF-beta 1 induced a rapid and transient increase in
PKC
phosphotransferase activity. TGF-beta 1, however, was unable to induce
PKC
enzymatic activity in cells pretreated with calphostin C. Therefore, it is concluded that TGF-beta 1 regulates the CEA responses through a signal transducing pathway associated with
PKC
.
...
PMID:Role of protein kinase C in transforming growth factor-beta 1 induction of carcinoembryonic antigen in human colon carcinoma cells. 138 May 12
We have investigated the role of protracted phosphatase inhibition and the consecutive protracted protein phosphorylation on neuronal viability. We found that in primary cultures of cerebellar granule neurons, the protracted (24-h) inhibition of the serine/threonine protein phosphatases 1 and 2A (EC 3.1.3.16) by treatment of the cultures with okadaic acid (OKA; 5-20 nM) caused neurotoxicity that could be inhibited by the protein kinase inhibitor 1-(5-isoquinolinylsulfonyl)-
2-methylpiperazine
(H7) or by the previous down-regulation of the neuronal protein kinase C (
PKC
; ATP:protein phosphotransferase; EC 2.7.1.37).
PKC
was down-regulated by exposure of the cultures for 24 h to 100 nM phorbol 12-myristate 13-acetate (TPA). The effect of the drugs used in the viability studies on the pattern of protein phosphorylation was measured by quantitative autoradiography. In particular, the 50- and 80-kDa protein bands showed dramatic changes in the degree of phosphorylation: increase by OKA and brief TPA treatment; decrease by H7 or 24 h of TPA treatment; and inhibition of the OKA-induced increase by H7 or 24 h of TPA treatment. The results suggest that the protracted phosphorylation, in particular that mediated by
PKC
, may lead to neuronal death and are in line with our previous suggestion that prolonged
PKC
translocation is operative in glutamate neurotoxicity.
...
PMID:Pathological phosphorylation causes neuronal death: effect of okadaic acid in primary culture of cerebellar granule cells. 140 5
Addition of transforming growth factor alpha (TGF-alpha) to cultured human keratinocytes results in enhanced expression of TGF-alpha mRNA. This phenomenon of TGF-alpha autoinduction is also observed in a TGF-alpha responsive colon cancer cell line, LIM 1215. In the present study, regulation of TGF-alpha autoinduction is examined in these two cell types. In human keratinocytes, but not in LIM 1215 cells, the increase in steady-state TGF-alpha mRNA following administration of TGF-alpha is due to stabilization of the 4.8-kilobase TGF-alpha transcript, as determined by actinomycin D decay curves. Nuclear run-on experiments confirmed transcriptional control in LIM 1215 cells. Basal and TGF-alpha-stimulated TGF-alpha expression is mediated, at least in part, through a
protein kinase C
-dependent pathway in both cell types, as determined by the protein kinase C inhibitor 1-(5-isoquinolinylsulfonyl)-
2-methylpiperazine
(H7), which attenuates TGF-alpha mRNA accumulation. In the keratinocytes, but not in the LIM 1215 cells, basal TGF-alpha expression is mediated through an epidermal growth factor receptor-dependent pathway, as determined by antibody blockade of the epidermal growth factor receptor. Thus, differential regulation of TGF-alpha autoinduction exists in these nontransformed and transformed epithelial cell types.
...
PMID:Differential regulation of transforming growth factor alpha autoinduction in a nontransformed and transformed epithelial cell. 141 97
Recent studies have suggested that
protein kinase C
(
PKC
) may be involved in the mechanism of signal transduction by which members of the interferon (IFN) family regulate gene expression and cell phenotype. We have investigated the role of
PKC
in the control of cell growth and gene expression by IFN alpha in Daudi cells. Treatment of these cells with two analogues of staurosporine, which are potent inhibitors of
PKC
, completely blocked the induction by IFN alpha of the mRNA for 2',5'-oligoadenylate synthetase and the 6-16 gene. These compounds also inhibited cell proliferation and thymidine incorporation in this system. In contrast, the protein kinase inhibitor 1-(5-isoquinolinylsulphonyl)-
2-methylpiperazine
(H7) did not significantly inhibit the induction of these genes by IFN alpha and had no effect on Daudi cell growth or thymidine incorporation in the presence or absence of IFN alpha. No effect of IFN alpha on total
PKC
activity could be observed, and there were no significant changes in the overall levels of individual
PKC
isoforms or their mRNA following IFN alpha treatment. In contrast, treatment of Daudi cells with the phorbol ester 12-O-tetradecanoylphorbol 13-acetate, which also inhibits cell proliferation, strongly down-regulated
PKC
. These data suggest that the activity of a
PKC
species, or a closely related enzyme, may be required both for continued cell proliferation and the response to IFN alpha in Daudi cells, but that IFN-induced growth inhibition does not involve overall down-regulation or change in activity of
PKC
.
...
PMID:Role of protein kinase C in induction of gene expression and inhibition of cell proliferation by interferon alpha. 142 89
12-O-Tetradecanoylphorbol 13-acetate (TPA), an activator of
protein kinase C
(
PKC
), induced ornithine decarboxylase (ODC) in primary cultured mouse epidermal cells. Staurosporine, a potent protein kinase C inhibitor, also induced ODC activity. Both TPA- and staurosporine-caused ODC inductions were markedly suppressed in the
PKC
-down-regulated cells. Another
PKC
inhibitor, 1-(5-isoquinolinesulfonyl)-
2-methylpiperazine
(H-7), inhibited both TPA- and staurosporine-caused ODC inductions. H-7 by itself never induced ODC activity. Under our experimental conditions, staurosporine induced no detectable phosphorylation of endogenous proteins. TPA induced a translocation of
PKC
from cytosol to membrane whereas an optimal concentration of staurosporine to induce ODC did not induce an obvious translocation of
PKC
. Indomethacin, a cyclooxygenase inhibitor, inhibited staurosporine-caused ODC induction, but not TPA-caused ODC induction. Staurosporine induced specific morphological changes of epidermal cells both in normal and in
PKC
-down-regulated cells. These results indicate that staurosporine induces ODC activity in a
PKC
-dependent manner and morphological changes possibly through a
PKC
-independent mechanism. The mechanism of ODC induction caused by staurosporine may be in some way different from that caused by TPA.
...
PMID:Protein kinase C-dependent and -independent actions of a potent protein kinase C inhibitor, staurosporine. 142 27
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>